ArticleJournal for immunotherapy of cancer2019

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors.

Deborah Ayeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.